Kymera Therapeutics files initial beneficial ownership statement for Chief Medical Officer Terence RooneyPUBT·1 day ago, 05:26 PMKYMR-3.53%
Kymera Therapeutics names Terence Rooney chief medical officer as Jared Gollob retiresPUBT·1 day ago, 03:01 PMKYMR-3.53%
Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law FirmPR Newswire·1 day ago, 07:49 AMKYMR-3.53%
Capital Reallocation on Wall Street’s Fringes: AI Spillovers and Cross-Border HeadwindsGlobal Report·Jul 24 at 04:13 AMKYMR-3.53%ALVU
11:13 ETSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)prnewswire·Jul 16 at 10:13 AMKYMR-3.53%
Does Leadership Hire And Benchmark Additions Change The Bull Case For Kymera Therapeutics (KYMR)?Simplywall·Jul 10 at 12:02 PMKYMR-3.53%
Kymera CEO Nello Mainolfi disposes of USD 5.95 million in common sharesPUBT·Jul 7 at 07:01 PMKYMR-3.53%
Kymera Therapeutics appoints Elizabeth Laws as SVP, KT-621 development program leaderPUBT·Jul 7 at 06:02 AMKYMR-3.53%
